A preliminary investigation of the pharmacokinetics and pharmacodynamics of amikacin/fosfomycin combination against Acinetobacter baumannii using a dynamic in vitro hollow-fibre infection model (2015–2016)

Grant type:
Cardeas Pharma Corporation
Researchers:
  • NHMRC Leadership Fellow
    Faculty of Medicine
    Director, UQ Centre for Clinical Re
    Faculty of Medicine
    Director, UQ Centre for Clinical Re
    Faculty of Medicine
    Centre Director of UQ Centre for Cl
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Cardeas Pharma Corporation